Understanding the offer

Start with the exact name.

An offer is easier to check when the name on the page matches the name being discussed at the visit.

If the name is BPC-157

The Food and Drug Administration (FDA) has no record of an approved US drug product for BPC-157, as of September 2026.

BPC-157 is the name of a peptide, rather than the name of a care plan. Ask how the proposed product is made and what evidence is being used for your joint problem.

If the name is TB-500

The FDA’s June 2023 letter described BPC-157 and TB-500 products as drugs without approval whose sale broke federal law.

The letter states the FDA’s accusation against that seller; it is not a court decision about every seller.

For another offer, ask which rule allows that exact medicine to be supplied. Ask to see the rule in writing, with its name or number.

A prescription is an order for medicine, written by a doctor or other health professional who is legally allowed to prescribe.

Compounding is the process of making or mixing medicine for a patient.

When a pharmacy prepares medicine for a patient named in the prescription, that order alone does not permit BPC-157 or TB-500 as raw ingredients under those rules.

Ask the pharmacy to show which ingredient rule it meets, not just to say yes. The pharmacy-rule page explains those checks.